Smart Money Alert

Emcure Pharmaceuticals Limited

New PositionBlock Deal

EMCUREPharmaceuticalsMarket Cap₹37K Cr

Value

₹25.00 Cr

1,37,592

Price

₹1,817

BNP Paribas

Foreign Investor

The move

BNP Paribas bought 137,592 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.

About Emcure Pharmaceuticals Limited

Visit stock

A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.

About BNP Paribas

Visit investor

French global bank with around EUR 2.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.

Get the next move the moment it happens.

Follow BNP Paribas and Emcure Pharmaceuticals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Emcure Pharmaceuticals Limited shareholders BNP Paribas's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Emcure Pharmaceuticals Limited

Morgan StanleyNew position

Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.

25 Jun 2026

HSBC Mutual FundNew position

HSBC Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1,817.00 apiece in a block deal.